Dual Immunotherapy Enhances Progression-Free Survival in Advanced Squamous Cell Skin Cancer: Findings from the Alliance Trial
In a significant advancement for the treatment of advanced cutaneous squamous cell carcinoma (cSCC), a phase II clinical trial spearheaded ...
